Stay updated on Regeneron Press Releases

Sign up to get notified when there's something new on the Regeneron Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Regeneron Press Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment (December 7, 2025 4:30 PM EST). Removed Regeneron Reports Third Quarter 2025 Financial and Operating Results (October 28, 2025 6:30 AM EDT).
    Difference
    2%
    Check dated 2025-12-08T23:30:05.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added two new press releases to the list: TSRA-196 gene editing therapy with Tessera Therapeutics and Dupixent EU approval for CSU. Removed two older press releases dated Oct 17 and Oct 15, 2025.
    Difference
    6%
    Check dated 2025-12-01T20:29:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added two new press releases on November 19, 2025 (FDA approval of EYLEA HD for macular edema following RVO and EU approval of Libtayo for adjuvant CSCC) and removed two older items (DB-OTO NEJM hearing/speech study and Libtayo CSCC US approval).
    Difference
    6%
    Check dated 2025-11-24T17:48:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new press release entry for November 13, 2025 was added to the Press Releases page, and an older press release listing was removed.
    Difference
    2%
    Check dated 2025-11-17T17:27:25.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added three November 2025 press releases to the page: Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at the American Heart Association Scientific Sessions and Published in The Lancet; Dupixent® Pivotal Trial results; Regeneron Announces Investor Conference Presentations. Removed three September 2025 releases (Evkeeza ANGPTL3 antibody approval, Dupixent CSU CHMP advancement, Regeneron Ebola donation).
    Difference
    6%
    Check dated 2025-11-10T13:44:26.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Two new press releases were added: Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award (Oct 31, 2025) and Regeneron Reports Third Quarter 2025 Financial and Operating Results (Oct 28, 2025). Older items dated Sept 17, 2025 were removed, and pagination controls were removed.
    Difference
    8%
    Check dated 2025-11-03T11:50:33.000Z thumbnail image

Stay in the know with updates to Regeneron Press Releases

Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.